Funding for this research was provided by:
National Natural Science Foundation of China (U1812403)
Guizhou Provincial Science and Technology Foundation (QKHRC2016-4018)
Received: 27 January 2022
Accepted: 9 September 2022
First Online: 20 September 2022
: The experimental animal protocol received ethical approval from the Laboratory Animal Ethics Committee of Guizhou Medical University (No. 2101032). Experiments were carried out in compliance with the ARRIVE guidelines. Normal human serum (NHS) was obtained from blood donated by three normal healthy volunteers (25–30 years old) in the research group. Informed written consent was obtained from all donated blood volunteers. The experiments were conducted according to the principles of the Declaration of Helsinki. The serum preparation protocol was reviewed by the Center for Pharmacology and Bioactivity Research, The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences. All methods were carried out in accordance with relevant guidelines and regulations in the declarations section.
: No applicable.
: The authors declare that they have no conflicts of interest regarding this work.